Bradesco Faces Analyst Downgrades as Insiders Buy
Banco Bradesco faced simultaneous analyst downgrades on October 28 as Itaú BBA and Citi cut ratings, citing a flat 2026 earnings outlook and weakening 2027 recovery expectations. Yet fourteen company
Two Analyst Downgrades Shadow Bradesco Q3 Push
NEW YORK, November 4 —
Banco Bradesco S.A. (BBD) completed a R$10 billion capital increase and posted double-digit loan growth in Q3 2026, then watched two independent sell-side firms downgrade the stock within 24 hours, citing a nearly flat 2026 earnings outlook and a 2027 recovery story already being marked down.
- Bradesco shares fell 5% on October 28 as Itaú BBA and Citi each cut their ratings the same day.
- The stock trades at 0.9x tangible book value, below its five-year average of 1.1x, with a 5.1x forward P/E.
- Fourteen insiders purchased $84.38 million in BBD shares between August 25 and September 29, with zero insider selling.
Capital Deployed, Recovery Deferred
Banco Bradesco operates Brazil's second-largest private bank, spanning retail and corporate lending, credit cards, investment management, and a substantial insurance arm covering life, pension, and health products. The R$10 billion capital raise announced on the October 22 earnings call was not distress financing, management paired it with deliberately shaped loan growth, steering credit toward payroll-deductible loans and corporate borrowers with guaranteed credit lines rather than unsecured personal lending. CEO Marcelo Noronha framed the posture plainly: "We continue to have traction, but we have traction where we have risk appetite." The strategy reads as a bank that has learned from prior NPL cycles, but the capital raise itself is a reminder that the balance sheet required reinforcing heading into what analysts now describe as a difficult 2027.
The Downgrade Logic Is About the Calendar, Not the Quarter
Itaú BBA analyst Pedro Leduc, writing from Bradesco's own principal rival, set a R$20 price target and downgraded to Market Perform on October 28 on the basis of a more challenging 2027 earnings outlook. Hours earlier, Citi's Gustavo Schroden had cut to Neutral from Buy. The simultaneous action by two independent firms signals a consensus read, not a coincidence. Analyst consensus already expects nearly flat EPS growth in 2026 after three misses in Bradesco's last four reported quarters, shortfalls of 6.3%, 6.0%, and 0.8%, and both firms flagged downside risk to the 13% EPS growth forecast for 2027. At 0.9x tangible book, the depressed valuation is not, per Itaú BBA, sufficient reason to buy until those 2027 estimates stop moving lower. The sell-off was sector-wide, Itaú Unibanco (ITUB) and Santander Brasil (BSBR) each fell roughly 4%, Nu Holdings (NU) fell roughly 3%, amplified by Santander Brasil's own Q3 showing pressure on net interest income the same day.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| BBD | $27.6B | 5.1x | -24.9% |
| ITUB | $77.7B | 7.3x | +0.1% |
| GGB | $9.1B | 6.9x | +35.7% |
| ABEV | $40.7B | 12.7x | +12.6% |
| BSBR | $16.7B | 5.3x | -22.9% |
| SID | $947M | 7.8x | -56.1% |
Insider Conviction Against Analyst Caution Sets the Test
The clearest counter-signal is in the Form 4 filings: fourteen directors and executive officers collectively bought $84.38 million in BBD shares between late August and late September, with director Rubens Aguiar Alvarez alone acquiring 1,698,000 shares at $17.37 on September 1 for roughly $29.49 million. That purchasing happened at prices materially above where BBD trades today. The insider base does not share the caution that Leduc and Schroden do. The number that resolves this split is 2027 normalized EPS: if estimates stabilize above the current consensus before the next reporting cycle, the 0.9x book entry looks prescient; if they continue lower, the capital raise and loan-book build look like growth financed ahead of an earnings air pocket. Run the free Banco Bradesco S.A. deep-dive → to track where estimates move from here.
Current fundamentals, valuation and filing history for Banco Bradesco S.A. (BBD) are tracked on its Basis Report page.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why did analysts downgrade Bradesco?
Itaú BBA and Citi both cut their ratings on October 28, citing concerns about Bradesco's 2026 earnings outlook, which is nearly flat, and 2027 earnings recovery expectations that are being marked lower. Analyst consensus already expected nearly flat EPS growth in 2026 after three recent misses.
How much did insiders buy?
Fourteen directors and executive officers collectively purchased $84.38 million in BBD shares between late August and late September 2026. Director Rubens Aguiar Alvarez alone acquired 1,698,000 shares at $17.37 on September 1 for roughly $29.49 million.
What is Bradesco's current valuation?
Bradesco trades at 0.9x tangible book value, below its five-year average of 1.1x, with a 5.1x forward P/E. Analyst Itaú BBA argues this depressed valuation is not sufficient reason to buy until 2027 earnings estimates stop moving lower.
Did other Brazilian banks fall too?
Yes, the sell-off was sector-wide on October 28: Itaú Unibanco fell roughly 4%, Santander Brasil fell roughly 4%, and Nu Holdings fell roughly 3%. Santander Brasil also reported pressure on net interest income the same day.
How did Bradesco deploy the new capital?
Bradesco paired the R$10 billion capital raise with deliberately shaped loan growth, steering credit expansion toward payroll-deductible loans and corporate borrowers with guaranteed credit lines rather than unsecured personal lending. CEO Marcelo Noronha framed this strategy as having "traction where we have risk appetite."
Banco Bradesco completed a R$10 billion capital increase and reported double-digit loan growth on its October 22 earnings call — but within six days, two separate Wall Street firms issued downgrades in the same 24-hour window, citing a nearly flat 2026 earnings outlook and a tougher road ahead in 2027.